Satsuma Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$119.9M

200 transactions

Summary

Satsuma Pharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $106.9MSales: $2.7M21 insiders

Date	Insider	Type	Value
2023-06-08	Shin Nippon Biomedical Laboratories, Ltd.	Buy	$7.7M
2023-06-08	Harsch Mutya	D	$0
2023-06-08	Harsch Mutya	D	$0
2023-06-08	KING THOMAS BRAXTON	D	$0
2023-06-08	KING THOMAS BRAXTON	D	$0
2023-06-08	KING THOMAS BRAXTON	D	$0
2023-06-08	KING THOMAS BRAXTON	D	$0
2023-06-08	KING THOMAS BRAXTON	D	$0
2023-06-08	KING THOMAS BRAXTON	D	—
2023-06-08	Lukatch Heath	D	$0
2023-06-08	Lukatch Heath	D	$0
2023-06-08	Lukatch Heath	D	$0
2023-06-08	Kollins John A(President and CEO)	D	$0
2023-06-08	Kollins John A(President and CEO)	D	$0
2023-06-08	Kollins John A(President and CEO)	D	$0
2023-06-08	Kollins John A(President and CEO)	D	$0
2023-06-08	Kollins John A(President and CEO)	D	$0
2023-06-08	Kollins John A(President and CEO)	D	—
2023-06-08	Kollins John A(President and CEO)	D	—
2023-06-08	Soloway Thomas P	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Satsuma Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope